Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2024 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.
Yang Y, Knoll MD, Herbert C, Bennett JC, Feikin DR, Garcia Quesada M, Hetrich MK, Zeger SL, Kagucia EW, Xiao M, Cohen AL, van der Linden M, du Plessis M, Yildirim I, Winje BA, Varon E, Valenzuela MT, Valentiner-Branth P, Steens A, Scott JA, Savrasova L, Sanz JC, Khan AS, Oishi K, Nzoyikorera N, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mackenzie GA, MacDonald L, Ladhani SN, Kristinsson KG, Kleynhans J, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Hammitt LL, Guevara M, Gilkison C, Gierke R, Desmet S, De Wals P, Dagan R, Colzani E, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Ampofo K, O'Brien KL, Hayford K; PSERENADE Team. Yang Y, et al. J Infect. 2025 Mar;90(3):106426. doi: 10.1016/j.jinf.2025.106426. Epub 2025 Jan 27. J Infect. 2025. PMID: 39864526 Free PMC article.
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) introduced in childhood national immunization programs lowered vaccine-type invasive pneumococcal disease (IPD), but replacement with non-vaccine-types persisted throughout the PCV10/13 follow-up period. ...
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) introduced in childhood national immunization programs lowered vaccine-type invasi …
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.
Bellitto C, Luxi N, Ciccimarra F, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Marques FB, Morton K, O'Shaughnessy F, Sonderlichová S, Farcas A, Janneke GE, Sturkenboom MC, Trifirò G. Bellitto C, et al. Drug Saf. 2024 Oct;47(10):1011-1023. doi: 10.1007/s40264-024-01449-x. Epub 2024 Jun 22. Drug Saf. 2024. PMID: 38907947 Free PMC article.
Participants filled baseline and up to six follow-up questionnaires (FU-Qs) over 6 months from vaccination, collecting information on suspected COVID-19 vaccine-related ADRs. As a control group, non-immunocompromised vaccinees from the same source population were 1:4 match …
Participants filled baseline and up to six follow-up questionnaires (FU-Qs) over 6 months from vaccination, collecting information on suspec …
The role of disease surveillance in maternal pertussis vaccination programmes in Europe: lessons for the future.
Ismail SA, Farnes K, Patel T, El Belghiti FA, Brisse S, Campbell CNJ, Campbell H, Gabutti G, González-López JJ, Knuutila A, van der Maas N, de Melker H, Mir-Cros A, Nohynek H, Toubiana J, Wichmann O, Ladhani SN, Khalil A, Amirthalingam G. Ismail SA, et al. Lancet Reg Health Eur. 2026 Oct 26;71:101902. doi: 10.1016/j.lanepe.2026.101902. eCollection 2026 Dec. Lancet Reg Health Eur. 2026. PMID: 42990667 Free PMC article. Review.
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.
Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad'arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K; The Pserenade Team. Deloria Knoll M, et al. Microorganisms. 2021 Apr 2;9(4):742. doi: 10.3390/microorganisms9040742. Microorganisms. 2021. PMID: 33918127 Free PMC article.
PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveillance was represented from all geographic regions but was limited from lower income and high-burden countries. ...With such a sizeable and g …
PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveil …